This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Autofluorescence in Uveitic and Diabetic Macular Edema

This study has been withdrawn prior to enrollment.
(Technical issue)
Information provided by (Responsible Party):
Carsten Heinz, St. Franziskus Hospital Identifier:
First received: August 10, 2009
Last updated: April 24, 2017
Last verified: April 2017
The aim of this study is to determine whether fundus autofluorescence and macular pigment distribution in inflammatory and diabetic macular edema are altered.

Uveitis Macular Edema

Study Type: Observational
Study Design: Observational Model: Case-Control
Time Perspective: Prospective

Resource links provided by NLM:

Further study details as provided by Carsten Heinz, St. Franziskus Hospital:

Enrollment: 0
Study Start Date: October 2010
Study Completion Date: June 1, 2016
Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)
uveitic patients
patients with diabetes

Detailed Description:
After macular pigment measuring we will perform fundus autofluorescence, fluorescein angiography and optical coherence tomography. any associations of macular pigment distribution and fundus autofluorescence with macular anatomic features are analyzed. primary outcome measure is the macular pigment distribution in patients with altered fundus autofluorescence. Furthermore we will compare the findings between diabetic and inflammatory edema.

Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients with uveitis or diabetes

Inclusion Criteria:

  • patients with diabetic or uveitis macular edema

Exclusion Criteria:

  • children patients with known allergy to fluorescein
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00956124

Department of Ophthalmology at St Franziskus Hospital
Muenster, North-Rhine-Westfalia, Germany, 48145
Sponsors and Collaborators
St. Franziskus Hospital
  More Information

Responsible Party: Carsten Heinz, Head of Department, St. Franziskus Hospital Identifier: NCT00956124     History of Changes
Other Study ID Numbers: 2009-017-f-S
Study First Received: August 10, 2009
Last Updated: April 24, 2017

Additional relevant MeSH terms:
Macular Edema
Signs and Symptoms
Macular Degeneration
Retinal Degeneration
Retinal Diseases
Eye Diseases
Uveal Diseases processed this record on September 21, 2017